Cost-Effectiveness Analysis of Regorafenib versus Other Third-Line Treatments for Metastatic Colorectal Cancer
Jiayun Zhong,1 Yu Liu,2 Qian Fu,1 Dan Huang,2 Wenjun Gong,2 Jian Zou2 1Department of Pharmaceutical, the People’s Hospital of Pengzhou, Chengdu, Sichuan, 611930, People’s Republic of China; 2Department of Clinical Pharmacy, the People’s Hospital of Pengzhou, Chengdu, Sichuan, 611930, People’s Republ...
Guardat en:
| Autors principals: | , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Dove Medical Press
2024-06-01
|
| Col·lecció: | Cancer Management and Research |
| Matèries: | |
| Accés en línia: | https://www.dovepress.com/cost-effectiveness-analysis-of-regorafenib-versus-other-third-line-tre-peer-reviewed-fulltext-article-CMAR |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|